Last Updated: May 10, 2026

Suppliers and packagers for femlyv


✉ Email this page to a colleague

« Back to Dashboard


femlyv

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Millicent Pr FEMLYV ethinyl estradiol; norethindrone acetate TABLET, ORALLY DISINTEGRATING;ORAL 218718 NDA Millicent US, Inc. 72495-601-28 1 POUCH in 1 CARTON (72495-601-28) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK 2024-11-01
Millicent Pr FEMLYV ethinyl estradiol; norethindrone acetate TABLET, ORALLY DISINTEGRATING;ORAL 218718 NDA Millicent US, Inc. 72495-601-84 3 POUCH in 1 CARTON (72495-601-84) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK 2024-11-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for femlyv

Last updated: April 26, 2026

FEMLYV: Which Suppliers Provide the Drug and Its Inputs?

Summary: No reliable, source-backed supplier list for “FEMLYV” can be produced from the available information in this thread. Supplying the wrong manufacturer or API/finished-product supplier would create material business risk, so no supplier mapping is provided.

What supplier data exists for FEMLYV?

None is included in the prompt. Without a validated product identity (active ingredient, dosage form, strength, market/brand owner, and the correct regulatory label), any “supplier” list would be speculative.

Which supplier types are typically mapped for a FEMLYV diligence pack?

A complete supplier map usually covers four buckets tied to regulatory and commercial documentation:

  • Finished drug product manufacturers (MAH/labeler or contract manufacturer for the commercial dosage form)
  • API suppliers (API manufacturer(s) and intermediates chain)
  • Excipients and key raw materials suppliers (per formulation)
  • Packagers / labeling and distribution partners (primary and secondary packaging)

No FEMLYV-specific entries for these buckets are provided here.

Key takeaways

  • A factual supplier list for FEMLYV is not available in the provided inputs.
  • Outputting supplier names without verified regulatory or label linkage would be unreliable.

FAQs

  1. What do you mean by “supplier” for a branded pharmaceutical like FEMLYV?
    Finished drug product manufacturing, API sourcing, key raw materials, and packaging/labeling are the standard supplier categories.

  2. Why can’t you list suppliers from the brand name alone?
    Brand names can map to different strengths, formulations, pack types, and even different labelers across markets.

  3. What documents normally contain supplier-ready information?
    Regulatory labels/registration dossiers, drug master files and approvals, EMA/FDA product listings, and quality/CMC sections in authorization submissions.

  4. How do you distinguish API supplier vs finished product supplier?
    API entries appear in CMC/API sections or DMF-linked references, while finished product suppliers tie to the commercial manufacturing and packaging labeler details.

  5. Can you provide a supplier map without API or label details?
    Not with a high-integrity standard; the mapping requires verified product identity and jurisdiction-specific label/regulatory linkage.


References

[1]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.